Network pharmacology-based mechanism prediction and pharmacological validation of Bushenhuoxue formula attenuating postmenopausal osteoporosis in ovariectomized mice

Postmenopausal osteoporosis (PMOP) is a common bone disorder characterized by low bone mineral density and microstructure deterioration [1]. It is estimated that more than 15% of postmenopausal women over 50 years old are suffering in PMOP worldwide [2]. Most of them have low back pain, hunchback an...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenjie, Xia, Haowei, Zhu, Jin, Li, Hongting, Jin
Format: Book
Language:English
Published: Springer 2023
Subjects:
Online Access:https://link.springer.com/article/10.1186/s13018-023-03696-7
https://dlib.phenikaa-uni.edu.vn/handle/PNK/6765
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Postmenopausal osteoporosis (PMOP) is a common bone disorder characterized by low bone mineral density and microstructure deterioration [1]. It is estimated that more than 15% of postmenopausal women over 50 years old are suffering in PMOP worldwide [2]. Most of them have low back pain, hunchback and fragility fractures in different degrees [3]. Although there exist a large amount of anti-osteoporosis drugs such as active vitamin D, estrogen receptor modulators, bisphosphonates and parathyroid hormone [4], various undesirable effects limit their application and efficacy [5]. Natural products and herbs attract increasing attention for their potential anti-osteoporosis effects and relative safety